Lung cancer in women

被引:115
作者
Patel, JD [1 ]
机构
[1] Northwestern Univ, Div Hematol Oncol, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA
关键词
D O I
10.1200/JCO.2005.11.486
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lung cancer is the leading cause of cancer death in the United States and is responsible for 20,000 more deaths yearly in US women than breast cancer. Cigarette smoking is the major cause of lung cancer, and unfortunately, approximately 22 million US women smoke. Mounting evidence suggests that there are significant differences in lung cancer between the sexes. There is a difference in the histologic distribution of lung cancer, with glandular differentiation being more common in women. Genetic variation may account for differences in susceptibility, and hormonal and biologic factors may play a role in carcinogenesis. Lung cancer patients have few therapeutic options. A more thorough understanding of the heterogeneity of lung cancer across populations may lead to innovations in treatment and prevention strategies. (c) 2005 by American Society of Clinical Oncology.
引用
收藏
页码:3212 / 3218
页数:7
相关论文
共 83 条
[41]  
Keohavong P, 1996, CLIN CANCER RES, V2, P411
[42]   Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer - A randomized trial [J].
Kris, MG ;
Natale, RB ;
Herbst, RS ;
Lynch, TJ ;
Prager, D ;
Belani, CP ;
Schiller, JH ;
Kelly, K ;
Spiridonidis, H ;
Sandler, A ;
Albain, KS ;
Cella, D ;
Wolf, MK ;
Averbuch, SD ;
Ochs, JJ ;
Kay, AC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (16) :2149-2158
[43]   P53 mutations in lung tumours: Relationship to gender and lung DNA adduct levels [J].
Kure, EH ;
Ryberg, D ;
Hewer, A ;
Phillips, DH ;
Skaug, V ;
Baera, R ;
Haugen, A .
CARCINOGENESIS, 1996, 17 (10) :2201-2205
[44]   Bidirectional signaling between the estrogen receptor and the epidermal growth factor receptor [J].
Levin, ER .
MOLECULAR ENDOCRINOLOGY, 2003, 17 (03) :309-317
[45]   Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib [J].
Lynch, TJ ;
Bell, DW ;
Sordella, R ;
Gurubhagavatula, S ;
Okimoto, RA ;
Brannigan, BW ;
Harris, PL ;
Haserlat, SM ;
Supko, JG ;
Haluska, FG ;
Louis, DN ;
Christiani, DC ;
Settleman, J ;
Haber, DA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) :2129-2139
[46]   17-BETA-ESTRADIOL MIMICS LIGAND ACTIVITY OF THE C-ERBB2 PROTOONCOGENE PRODUCT [J].
MATSUDA, S ;
KADOWAKI, Y ;
ICHINO, M ;
AKIYAMA, T ;
TOYOSHIMA, K ;
YAMAMOTO, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (22) :10803-10807
[47]   EXPRESSION OF CYP1A1 GENE IN PATIENTS WITH LUNG-CANCER - EVIDENCE FOR CIGARETTE SMOKE-INDUCED GENE-EXPRESSION IN NORMAL LUNG-TISSUE AND FOR ALTERED GENE-REGULATION IN PRIMARY PULMONARY CARCINOMAS [J].
MCLEMORE, TL ;
ADELBERG, S ;
LIU, MC ;
MCMAHON, NA ;
YU, SJ ;
HUBBARD, WC ;
CZERWINSKI, M ;
WOOD, TG ;
STORENG, R ;
LUBET, RA ;
EGGLESTON, JC ;
BOYD, MR ;
HINES, RN .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (16) :1333-1339
[48]  
Mollerup S, 1999, CANCER RES, V59, P3317
[49]   Implications and prognostic value of K-ras mutation for early-stage lung cancer in women [J].
Nelson, HH ;
Christiani, DC ;
Mark, EJ ;
Wiencke, JK ;
Wain, JC ;
Kelsey, KT .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (23) :2032-2038
[50]   FREQUENCY AND PROGNOSTIC IMPORTANCE OF PRETREATMENT CLINICAL CHARACTERISTICS IN PATIENTS WITH ADVANCED NON SMALL-CELL LUNG-CANCER TREATED WITH COMBINATION CHEMOTHERAPY [J].
OCONNELL, JP ;
KRIS, MG ;
GRALLA, RJ ;
GROSHEN, S ;
TRUST, A ;
FIORE, JJ ;
KELSEN, DP ;
HEELAN, RT ;
GOLBEY, RB .
JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (11) :1604-1614